Unprecedented Year - Discuss at Tri-Con 2021! Over the past 27 years, Molecular Medicine Tri-Conference has served as the leading international meeting place for the precision medicine community. As we...
For more than 20 years, the BIO CEO & Investor Conference has fueled biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and...
Building upon nearly 70 years of research in sickle cell disease (SCD) pathology, voxelotor, an HbS polymerization inhibitor, was developed to treat the root cause of SCD pathophysiology. In 2019,...
